BSX

HOLD

Boston Scientific Corporation

Healthcare · Rank #37 · Analyzed Jul 13, 2026

$44.77

Current Price

$55.57

Intrinsic Value

+24.1%

Upside/Downside

5.7/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score3.5/5.0

Framework RatingHOLD

Price vs Intrinsic ValueUndervalued by 24.1%

Fair Value Range

Low$15.36

Base (IV)$55.57

High$78.56

Entry Points

Conservative$10.75

Moderate$15.36

Aggressive$38.90

Quality & Moat Breakdown

Return on Equity14.7% → 0.5/1.0

Debt LevelD/E 42 → 0.5/1.0

Revenue QualityGrowth 18.7%, margin Δ+3.7% +recovery → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins17.3% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.